Pharming Group N.V. (PHAR) Ownership

NASDAQ: PHARTop holders, insider trades and short interest.

PHAR ownership summary

as of October 18, 2026
Institutions
0.1%
of shares outstanding
Insiders
0.00%
of shares outstanding
Shares outstanding
70.8M
Float
69.7M
shares available to trade
Short interest
0.03%
20K shares short
Days to cover
0.57
short interest down 3.8% vs prior month
  • Institutions 0.13%
  • Other investors 99.87%

PHAR top institutional holders

20 largest
Pharming Group N.V. top institutional holders
#Holder% of sharesSharesValueChangeReported
1MAC Alpha Capital Management, LP3.04%2.1M$20.1M+2.1M (0.0%)June 30, 2026
2Silverberg Bernstein Capital Management LLC0.06%42K$388,880−3,200 (−7.2%)June 30, 2026
3Crossmark Global Holdings, Inc.0.02%12K$116,654+12,463 (0.0%)June 30, 2026
4Citadel Advisors Llc0.02%12K$112,058+1,783 (+17.5%)June 30, 2026
5Morgan Stanley - Brokerage Accounts0.02%12K$107,640+11 (+0.1%)June 30, 2026
6SmartHarvest Portfolios, LLC0.01%10K$97,484−382 (−3.5%)June 30, 2026
7Knoll Capital Management LP0.01%4,091$38,292+34 (+0.8%)June 30, 2026
8Silver Grove Financial Group, Inc.<0.01%1,071$10,025+1,071 (0.0%)June 30, 2026
9Nalls Sherbakoff Group, LLC<0.01%870$8,143—June 30, 2026
10Global Retirement Partners, LLC.<0.01%456$4,268+374 (+456.1%)June 30, 2026
11Integrated Wealth Concepts LLC<0.01%380$3,557+380 (0.0%)June 30, 2026
12Optiver Holding B.V.<0.01%305$2,855+305 (0.0%)June 30, 2026
13BNP Paribas Arbitrage, SA<0.01%300$2,808−100 (−25.0%)June 30, 2026
14Goss Wealth Management LLC<0.01%187$1,750−1,963 (−91.3%)June 30, 2026
15UBS Group AG<0.01%39$365+39 (0.0%)June 30, 2026
16Advisor Group Holdings, Inc.0.00%16$150−112 (−87.5%)June 30, 2026
17Larson Financial Group, LLC0.00%7$66−336 (−98.0%)June 30, 2026
18Caitong International Asset Management Co., Limited.0.00%1$9+1 (0.0%)June 30, 2026
19EverSource Wealth Advisors, LLC0.00%——−557 (−100.0%)June 30, 2026
20Cornerstone Financial Management, LLC0.00%——−32 (−100.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 2.2M shares and 8 cut 6,682.

PHAR top mutual fund and ETF holders

3 largest
Pharming Group N.V. top fund holders
#Holder% of sharesSharesValueChangeReported
1Steward Values Enhanced International I0.02%12K$116,654—August 31, 2026
2MINT GLOBAL SMALL CAPS FIF ACOES<0.01%2,790$26,114+2,790 (0.0%)June 30, 2026
3Fidelity Nasdaq Composite Index<0.01%2,093$19,590—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

PHAR shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns PHAR

Institutional investors own 0.1% of Pharming's shares and insiders 0.00%. The largest holder is MAC Alpha Capital Management, LP with 3.04% of the shares (2.1M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 8 reduced their stake in the latest filings. Short interest is 0.03% of the float, or 0.57 days of average trading volume. The share count rose 47.4% since 2014.

Related: PHAR analyst forecast, PHAR key metrics. See the PHAR stock overview for the latest quote and news.

PHAR ownership FAQ

Who owns the most Pharming stock?

The largest shareholders of Pharming are MAC Alpha Capital Management, LP (3.04%), Silverberg Bernstein Capital Management LLC (0.06%), Crossmark Global Holdings, Inc. (0.02%), Citadel Advisors Llc (0.02%), Morgan Stanley - Brokerage Accounts (0.02%).

What percentage of Pharming is owned by institutions?

Institutions hold 0.1% of Pharming's shares outstanding; insiders hold 0.00%.

Which funds own Pharming?

The largest fund holders of Pharming are Steward Values Enhanced International I (0.02%), MINT GLOBAL SMALL CAPS FIF ACOES (<0.01%), Fidelity Nasdaq Composite Index (<0.01%).

What is Pharming's short interest?

20K shares of Pharming were sold short, 0.03% of the float; at the average daily volume it would take 0.57 days to cover.

How many shares of Pharming are outstanding?

Pharming has 70.8M shares outstanding, of which 69.7M are in the public float.

Biotechnology: ownership